Top Cleveland Clinic and University of Iowa eye doctors explain it's not just blurry vision or irritation—and not just any ...

Lupin Limited secures FDA approval for Loteprednol Etabonate Ophthalmic Gel, enhancing treatment options for postoperative ...

Lupin share price gained in the early trade on July 2 on the back of USFDA approval for Loteprednol Etabonate Ophthalmic Gel. At 09:20am, Lupin was quoting at Rs 1,969.70, up Rs 8.40, or 0.43 ...

According to IQVIA MAT data for May 2025, Loteprednol Etabonate Ophthalmic Gel, 0.38% (Reference Listed Drug: Lotemax (R) SM) had estimated annual sales of $29 million in the U.S.

Lupin today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New ...